메뉴 건너뛰기




Volumn 153, Issue 6, 2011, Pages 681-697

Antifungal prophylaxis during treatment for haematological malignancies: Are we there yet?

Author keywords

Antifungal prophylaxis; Invasive aspergillosis; Invasive fungal disease; Leukaemia; Stem cell transplantation

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CASPOFUNGIN; CYCLODEXTRIN; CYCLOPHOSPHAMIDE; FLUCONAZOLE; INFLIXIMAB; ITRACONAZOLE; MICAFUNGIN; MICONAZOLE; NYSTATIN; PLACEBO; POLYENE; POSACONAZOLE; PREDNISOLONE; STEROID; VINCA ALKALOID; VORICONAZOLE;

EID: 79957548786     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08650.x     Document Type: Review
Times cited : (47)

References (124)
  • 3
    • 58349122651 scopus 로고    scopus 로고
    • Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients
    • Barnes, R.A., White, P.L., Bygrave, C., Evans, N., Healy, B. & Kell, J. (2009) Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients. Journal of Clinical Pathology, 62, 64-69.
    • (2009) Journal of Clinical Pathology , vol.62 , pp. 64-69
    • Barnes, R.A.1    White, P.L.2    Bygrave, C.3    Evans, N.4    Healy, B.5    Kell, J.6
  • 4
    • 77955148951 scopus 로고    scopus 로고
    • Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection
    • Ben-Ami, R., Lewis, R.E. & Kontoyiannis, D.P. (2010) Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection. British Journal of Haematology, 150, 406-417.
    • (2010) British Journal of Haematology , vol.150 , pp. 406-417
    • Ben-Ami, R.1    Lewis, R.E.2    Kontoyiannis, D.P.3
  • 5
    • 0037096886 scopus 로고    scopus 로고
    • Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials
    • Bow, E.J., Laverdiere, M., Lussier, N., Rotstein, C., Cheang, M.S. & Ioannou, S. (2002) Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials. Cancer, 94, 3230-3246.
    • (2002) Cancer , vol.94 , pp. 3230-3246
    • Bow, E.J.1    Laverdiere, M.2    Lussier, N.3    Rotstein, C.4    Cheang, M.S.5    Ioannou, S.6
  • 6
    • 0025117876 scopus 로고
    • Management of fungal infection in neutropenic patients with fluconazole
    • Brammer, K.W. (1990) Management of fungal infection in neutropenic patients with fluconazole. Haematology & Blood Transfusion, 33, 546-550.
    • (1990) Haematology & Blood Transfusion , vol.33 , pp. 546-550
    • Brammer, K.W.1
  • 8
    • 8744314133 scopus 로고    scopus 로고
    • Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation
    • van Burik, J.A., Ratanatharathorn, V., Stepan, D.E., Miller, C.B., Lipton, J.H. & Vesole, D.H. (2004) Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Clinical Infectious Diseases, 39, 1407-1416.
    • (2004) Clinical Infectious Diseases , vol.39 , pp. 1407-1416
    • van Burik, J.A.1    Ratanatharathorn, V.2    Stepan, D.E.3    Miller, C.B.4    Lipton, J.H.5    Vesole, D.H.6
  • 9
    • 33644832215 scopus 로고    scopus 로고
    • Update on antifungal drug resistance mechanisms of Aspergillus fumigatus
    • Chamilos, G. & Kontoyiannis, D.P. (2006) Update on antifungal drug resistance mechanisms of Aspergillus fumigatus. Drug Resistance Updates, 8, 344-358.
    • (2006) Drug Resistance Updates , vol.8 , pp. 344-358
    • Chamilos, G.1    Kontoyiannis, D.P.2
  • 19
    • 53349157204 scopus 로고    scopus 로고
    • Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation
    • Garcia-Vidal, C., Upton, A., Kirby, K.A. & Marr, K.A. (2008) Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clinical Infectious Diseases, 47, 1041-1050.
    • (2008) Clinical Infectious Diseases , vol.47 , pp. 1041-1050
    • Garcia-Vidal, C.1    Upton, A.2    Kirby, K.A.3    Marr, K.A.4
  • 21
    • 59549093782 scopus 로고    scopus 로고
    • Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT
    • Gil, L., Kozlowska-Skrzypczak, M., Mol, A., Poplawski, D., Styczynski, J. & Komarnicki, M. (2009) Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT. Bone Marrow Transplantation, 43, 121-126.
    • (2009) Bone Marrow Transplantation , vol.43 , pp. 121-126
    • Gil, L.1    Kozlowska-Skrzypczak, M.2    Mol, A.3    Poplawski, D.4    Styczynski, J.5    Komarnicki, M.6
  • 23
    • 1542438612 scopus 로고    scopus 로고
    • Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients
    • Glasmacher, A., Prentice, A., Gorschluter, M., Engelhart, S., Hahn, C. & Djulbegovic, B. (2003) Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3, 597 patients. Journal of Clinical Oncology, 21, 4615-4626.
    • (2003) Journal of Clinical Oncology , vol.21 , pp. 4615-4626
    • Glasmacher, A.1    Prentice, A.2    Gorschluter, M.3    Engelhart, S.4    Hahn, C.5    Djulbegovic, B.6
  • 25
    • 0001348302 scopus 로고
    • Amphotericins A and B, antifungal antibiotics produced by a streptomycete. I. In vitro studies
    • Gold, W., Stout, H.A., Pagano, J.F. & Donovick, R. (1956) Amphotericins A and B, antifungal antibiotics produced by a streptomycete. I. In vitro studies. Antibiotics Annual 1955-1956, 3, 579-586.
    • (1956) Antibiotics Annual 1955-1956 , vol.3 , pp. 579-586
    • Gold, W.1    Stout, H.A.2    Pagano, J.F.3    Donovick, R.4
  • 27
    • 33644830188 scopus 로고    scopus 로고
    • Misleading statements in industry-sponsored meta-analysis of itraconazole
    • Gotzsche, P.C. & Johansen, H.K. (2005) Misleading statements in industry-sponsored meta-analysis of itraconazole. Journal of Clinical Oncology, 23, 9428-9429.
    • (2005) Journal of Clinical Oncology , vol.23 , pp. 9428-9429
    • Gotzsche, P.C.1    Johansen, H.K.2
  • 28
    • 77957828768 scopus 로고    scopus 로고
    • Accuracy of bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis: a bivariate meta-analysis and systematic review
    • Guo, Y.L., Chen, Y.Q., Wang, K., Qin, S.M., Wu, C. & Kong, J.L. (2010) Accuracy of bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis: a bivariate meta-analysis and systematic review. Chest, 138, 817-824.
    • (2010) Chest , vol.138 , pp. 817-824
    • Guo, Y.L.1    Chen, Y.Q.2    Wang, K.3    Qin, S.M.4    Wu, C.5    Kong, J.L.6
  • 32
    • 69849111376 scopus 로고    scopus 로고
    • Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients
    • Harnicar, S., Adel, N. & Jurcic, J. (2009) Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients. Journal of Oncology Pharmacy Practice, 15, 175-182.
    • (2009) Journal of Oncology Pharmacy Practice , vol.15 , pp. 175-182
    • Harnicar, S.1    Adel, N.2    Jurcic, J.3
  • 33
    • 0033919037 scopus 로고    scopus 로고
    • Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B
    • Harousseau, J.L., Dekker, A.W., Stamatoullas-Bastard, A., Fassas, A., Linkesch, W., Gouveia, J., De Bock, R., Rovira, M., Seifert, W.F., Joosen, H., Peeters, M. & De Beule, K. (2000) Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B. Antimicrobial Agents and Chemotherapy, 44, 1887-1893.
    • (2000) Antimicrobial Agents and Chemotherapy , vol.44 , pp. 1887-1893
    • Harousseau, J.L.1    Dekker, A.W.2    Stamatoullas-Bastard, A.3    Fassas, A.4    Linkesch, W.5    Gouveia, J.6    De Bock, R.7    Rovira, M.8    Seifert, W.F.9    Joosen, H.10    Peeters, M.11    De Beule, K.12
  • 35
    • 40749161536 scopus 로고    scopus 로고
    • Beta-D-glucan detection test: a step towards preemptive therapy for fungal infections in leukaemic patients?
    • Herbrecht, R. & Berceanu, A. (2008) Beta-D-glucan detection test: a step towards preemptive therapy for fungal infections in leukaemic patients? Clinical Infectious Diseases, 46, 886-889.
    • (2008) Clinical Infectious Diseases , vol.46 , pp. 886-889
    • Herbrecht, R.1    Berceanu, A.2
  • 39
    • 77953809369 scopus 로고    scopus 로고
    • Exposure-response of posaconazole used for prophylaxis against invasive fungal infections: evaluating the need to adjust doses based on drug concentrations in plasma
    • Jang, S.H., Colangelo, P.M. & Gobburu, J.V. (2010) Exposure-response of posaconazole used for prophylaxis against invasive fungal infections: evaluating the need to adjust doses based on drug concentrations in plasma. Clinical Pharmacology & Therapeutics, 88, 115-119.
    • (2010) Clinical Pharmacology & Therapeutics , vol.88 , pp. 115-119
    • Jang, S.H.1    Colangelo, P.M.2    Gobburu, J.V.3
  • 40
    • 0034565160 scopus 로고    scopus 로고
    • Amphotericin B lipid soluble formulations vs amphotericin B in cancer patients with neutropenia
    • Johansen, H.K. & Gotzsche, P.C. (2000) Amphotericin B lipid soluble formulations vs amphotericin B in cancer patients with neutropenia. Cochrane Database Systematic Reviews, 3, CD000969.
    • (2000) Cochrane Database Systematic Reviews , vol.3
    • Johansen, H.K.1    Gotzsche, P.C.2
  • 41
    • 0036042977 scopus 로고    scopus 로고
    • Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients
    • Johansen, H.K. & Gotzsche, P.C. (2002) Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients. Cochrane Database Systematic Reviews, 2, CD000239.
    • (2002) Cochrane Database Systematic Reviews , vol.2
    • Johansen, H.K.1    Gotzsche, P.C.2
  • 43
    • 0032913885 scopus 로고    scopus 로고
    • Liposomal amphotericin B (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomized, double-blind, placebo-controlled study
    • Kelsey, S.M., Goldman, J.M., McCann, S., Newland, A.C., Scarffe, J.H., Oppenheim, B.A. & Mufti, G.J. (1999) Liposomal amphotericin B (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomized, double-blind, placebo-controlled study. Bone Marrow Transplantation, 23, 163-168.
    • (1999) Bone Marrow Transplantation , vol.23 , pp. 163-168
    • Kelsey, S.M.1    Goldman, J.M.2    McCann, S.3    Newland, A.C.4    Scarffe, J.H.5    Oppenheim, B.A.6    Mufti, G.J.7
  • 44
    • 0032527958 scopus 로고    scopus 로고
    • Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study
    • Kern, W., Behre, G., Rudolf, T., Kerkhoff, A., Grote-Metke, A., Eimermacher, H., Kubica, U., Wörmann, B., Büchner, T. & Hiddemann, W. (1998) Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. Cancer, 83, 291-301.
    • (1998) Cancer , vol.83 , pp. 291-301
    • Kern, W.1    Behre, G.2    Rudolf, T.3    Kerkhoff, A.4    Grote-Metke, A.5    Eimermacher, H.6    Kubica, U.7    Wörmann, B.8    Büchner, T.9    Hiddemann, W.10
  • 45
    • 0035867087 scopus 로고    scopus 로고
    • Guide to the development of practice guidelines
    • Kish, M.A. (2001) Guide to the development of practice guidelines. Clinical Infectious Diseases, 32, 851-854.
    • (2001) Clinical Infectious Diseases , vol.32 , pp. 851-854
    • Kish, M.A.1
  • 46
    • 79951671840 scopus 로고    scopus 로고
    • Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success
    • Kontoyiannis, D.P. (2011) Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success. Bone Marrow Transplantation, 46, 165-173.
    • (2011) Bone Marrow Transplantation , vol.46 , pp. 165-173
    • Kontoyiannis, D.P.1
  • 49
    • 63849233258 scopus 로고    scopus 로고
    • The changing face of epidemiology of invasive fungal disease in Europe
    • Lass-Florl, C. (2009) The changing face of epidemiology of invasive fungal disease in Europe. Mycoses, 52, 197-205.
    • (2009) Mycoses , vol.52 , pp. 197-205
    • Lass-Florl, C.1
  • 51
    • 75749148763 scopus 로고    scopus 로고
    • Fungal infections in leukemia patients: how do we prevent and treat them?
    • Leventakos, K., Lewis, R.E. & Kontoyiannis, D.P. (2010) Fungal infections in leukemia patients: how do we prevent and treat them? Clinical Infectious Diseases, 50, 405-415.
    • (2010) Clinical Infectious Diseases , vol.50 , pp. 405-415
    • Leventakos, K.1    Lewis, R.E.2    Kontoyiannis, D.P.3
  • 52
    • 0036532505 scopus 로고    scopus 로고
    • Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy
    • MacMillan, M.L., Goodman, J.L., DeFor, T.E. & Weisdorf, D.J. (2002) Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy. American Journal of Medicine, 112, 369-379.
    • (2002) American Journal of Medicine , vol.112 , pp. 369-379
    • MacMillan, M.L.1    Goodman, J.L.2    DeFor, T.E.3    Weisdorf, D.J.4
  • 56
    • 79957552733 scopus 로고    scopus 로고
    • Improvit Study Group. Voriconazole vs itraconazole for primary prophylaxis of invasive fungal infection in allogeneic hematopoietic cell transplant (HCT) recipients. In: 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. © American Society for Microbiology, Washington, D.C. Abstract 1249A.
    • Marks, D.I., Kibbler, C., Pagliuca, A., Ribaud, P., Solano, C., Huessel, C.P., Cook, G., Glasmacher, A., Schlamm, H. & Kantecki, M.; Improvit Study Group. (2009) Voriconazole vs itraconazole for primary prophylaxis of invasive fungal infection in allogeneic hematopoietic cell transplant (HCT) recipients. In: 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. © American Society for Microbiology, Washington, D.C. Abstract 1249A.
    • (2009)
    • Marks, D.I.1    Kibbler, C.2    Pagliuca, A.3    Ribaud, P.4    Solano, C.5    Huessel, C.P.6    Cook, G.7    Glasmacher, A.8    Schlamm, H.9    Kantecki, M.10
  • 57
    • 0034665657 scopus 로고    scopus 로고
    • Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial
    • Marr, K.A., Seidel, K., Slavin, M.A., Bowden, R.A., Schoch, H.G., Flowers, M.E.D., Corey, L. & Boeckh, M. (2000) Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood, 96, 2055-2061.
    • (2000) Blood , vol.96 , pp. 2055-2061
    • Marr, K.A.1    Seidel, K.2    Slavin, M.A.3    Bowden, R.A.4    Schoch, H.G.5    Flowers, M.E.D.6    Corey, L.7    Boeckh, M.8
  • 59
    • 0037114705 scopus 로고    scopus 로고
    • Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors
    • Marr, K.A., Carter, R.A., Boeckh, M., Martin, P. & Corey, L. (2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood, 100, 4358-4366.
    • (2002) Blood , vol.100 , pp. 4358-4366
    • Marr, K.A.1    Carter, R.A.2    Boeckh, M.3    Martin, P.4    Corey, L.5
  • 60
    • 0842328814 scopus 로고    scopus 로고
    • Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants
    • Marr, K.A., Crippa, F., Leisenring, W., Hoyle, M., Boeckh, M., Balajee, S.A., Nichols, W.G., Musher, B. & Corey, L. (2004a) Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Blood, 103, 1527-1533.
    • (2004) Blood , vol.103 , pp. 1527-1533
    • Marr, K.A.1    Crippa, F.2    Leisenring, W.3    Hoyle, M.4    Boeckh, M.5    Balajee, S.A.6    Nichols, W.G.7    Musher, B.8    Corey, L.9
  • 62
    • 20444371963 scopus 로고    scopus 로고
    • Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay
    • Marr, K.A., Laverdiere, M., Gugel, A. & Leisenring, W. (2005) Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clinical Infectious Diseases, 40, 1762-1769.
    • (2005) Clinical Infectious Diseases , vol.40 , pp. 1762-1769
    • Marr, K.A.1    Laverdiere, M.2    Gugel, A.3    Leisenring, W.4
  • 64
    • 0141928771 scopus 로고    scopus 로고
    • Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study
    • Marty, F.M., Lee, S.J., Fahey, M.M., Alyea, E.P., Soiffer, R.J., Antin, J.H. & Baden, L.R. (2003) Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study. Blood, 102, 2768-2776.
    • (2003) Blood , vol.102 , pp. 2768-2776
    • Marty, F.M.1    Lee, S.J.2    Fahey, M.M.3    Alyea, E.P.4    Soiffer, R.J.5    Antin, J.H.6    Baden, L.R.7
  • 65
    • 1342331879 scopus 로고    scopus 로고
    • Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants
    • Marty, F.M., Cosimi, L.A. & Baden, L.R. (2004) Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. New England Journal of Medicine, 350, 950-952.
    • (2004) New England Journal of Medicine , vol.350 , pp. 950-952
    • Marty, F.M.1    Cosimi, L.A.2    Baden, L.R.3
  • 66
  • 68
    • 78651490152 scopus 로고    scopus 로고
    • Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome
    • Mattiuzzi, G.N., Cortes, J., Alvarado, G., Verstovsek, S., Koller, C., Pierce, S., Blamble, D., Faderl, S., Xiao, L., Hernandez, M. & Kantarjian, H. (2011) Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome. Support Care Cancer, 19, 19-26.
    • (2011) Support Care Cancer , vol.19 , pp. 19-26
    • Mattiuzzi, G.N.1    Cortes, J.2    Alvarado, G.3    Verstovsek, S.4    Koller, C.5    Pierce, S.6    Blamble, D.7    Faderl, S.8    Xiao, L.9    Hernandez, M.10    Kantarjian, H.11
  • 72
    • 0032991690 scopus 로고    scopus 로고
    • A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. UK Multicentre Antifungal Prophylaxis Study Group
    • Morgenstern, G.R., Prentice, A.G., Prentice, H.G., Ropner, J.E., Schey, S.A. & Warnock, D.W. (1999) A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. UK Multicentre Antifungal Prophylaxis Study Group. British Journal of Haematology, 105, 901-911.
    • (1999) British Journal of Haematology , vol.105 , pp. 901-911
    • Morgenstern, G.R.1    Prentice, A.G.2    Prentice, H.G.3    Ropner, J.E.4    Schey, S.A.5    Warnock, D.W.6
  • 73
    • 58749083534 scopus 로고    scopus 로고
    • Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of multicenter prospective Antifungal Therapy (PATH) Path Alliance Registry
    • Neofytos, D., Horn, D., Anaissie, E., Steinbach, W., Olyaei, A., Fishman, J., Pfaller, M., Chang, C., Webster, K. & Marr, K. (2009) Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of multicenter prospective Antifungal Therapy (PATH) Path Alliance Registry. Clinical Infectious Diseases, 48, 265-273.
    • (2009) Clinical Infectious Diseases , vol.48 , pp. 265-273
    • Neofytos, D.1    Horn, D.2    Anaissie, E.3    Steinbach, W.4    Olyaei, A.5    Fishman, J.6    Pfaller, M.7    Chang, C.8    Webster, K.9    Marr, K.10
  • 74
    • 0035893122 scopus 로고    scopus 로고
    • Revisiting the source of candidemia: skin or gut?
    • Nucci, M. & Anaissie, E. (2001) Revisiting the source of candidemia: skin or gut? Clinical Infectious Diseases, 33, 1959-1967.
    • (2001) Clinical Infectious Diseases , vol.33 , pp. 1959-1967
    • Nucci, M.1    Anaissie, E.2
  • 79
    • 39449117139 scopus 로고    scopus 로고
    • Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes
    • Pascual, A., Calandra, T., Bolay, S., Buclin, T., Bille, J. & Marchetti, O. (2008) Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clinical Infectious Diseases, 46, 201-211.
    • (2008) Clinical Infectious Diseases , vol.46 , pp. 201-211
    • Pascual, A.1    Calandra, T.2    Bolay, S.3    Buclin, T.4    Bille, J.5    Marchetti, O.6
  • 80
    • 33846439749 scopus 로고    scopus 로고
    • Prophylaxis and aspergillosis - has the principle been proven?
    • de Pauw, B.E. & Donnelly, J.P. (2007) Prophylaxis and aspergillosis - has the principle been proven? New England Journal of Medicine, 356, 409-411.
    • (2007) New England Journal of Medicine , vol.356 , pp. 409-411
    • de Pauw, B.E.1    Donnelly, J.P.2
  • 81
    • 63649130507 scopus 로고    scopus 로고
    • Timely intervention for invasive fungal disease: should the road lead to the laboratory instead of the pharmacy?
    • de Pauw, B.E. & Donnelly, J.P. (2009) Timely intervention for invasive fungal disease: should the road lead to the laboratory instead of the pharmacy? Clinical Infectious Diseases, 48, 1052-1054.
    • (2009) Clinical Infectious Diseases , vol.48 , pp. 1052-1054
    • de Pauw, B.E.1    Donnelly, J.P.2
  • 83
    • 33747892111 scopus 로고    scopus 로고
    • Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial
    • Penack, O., Schwartz, S., Martus, P., Reinwald, M., Schmidt-Hieber, M., Thiel, E. & Blau, I.W. (2006) Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial. Annals of Oncology, 17, 1306-1312.
    • (2006) Annals of Oncology , vol.17 , pp. 1306-1312
    • Penack, O.1    Schwartz, S.2    Martus, P.3    Reinwald, M.4    Schmidt-Hieber, M.5    Thiel, E.6    Blau, I.W.7
  • 84
    • 42549119120 scopus 로고    scopus 로고
    • Aerosolized antifungal prophylaxis: the winds of change?
    • Perfect, J.R. (2008) Aerosolized antifungal prophylaxis: the winds of change? Clinical Infectious Diseases, 46, 1409-1411.
    • (2008) Clinical Infectious Diseases , vol.46 , pp. 1409-1411
    • Perfect, J.R.1
  • 86
    • 33646464211 scopus 로고    scopus 로고
    • Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis
    • Pfeiffer, C.D., Fine, J.P. & Safdar, N. (2006) Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clinical Infectious Diseases, 42, 1417-1427.
    • (2006) Clinical Infectious Diseases , vol.42 , pp. 1417-1427
    • Pfeiffer, C.D.1    Fine, J.P.2    Safdar, N.3
  • 87
    • 0027248742 scopus 로고
    • Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group
    • Philpott-Howard, J.N., Wade, J.J., Mufti, G.J., Brammer, K.W. & Ehninger, G. (1993) Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group. Journal of Antimicrobial Chemotherapy, 31, 973-984.
    • (1993) Journal of Antimicrobial Chemotherapy , vol.31 , pp. 973-984
    • Philpott-Howard, J.N.1    Wade, J.J.2    Mufti, G.J.3    Brammer, K.W.4    Ehninger, G.5
  • 90
    • 36849012946 scopus 로고    scopus 로고
    • Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis
    • Robenshtok, E., Gafter-Gvili, A., Goldberg, E., Weinberger, M., Yeshurun, M., Leibovici, L. & Paul, M. (2007) Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis. Journal of Clinical Oncology, 25, 5471-5489.
    • (2007) Journal of Clinical Oncology , vol.25 , pp. 5471-5489
    • Robenshtok, E.1    Gafter-Gvili, A.2    Goldberg, E.3    Weinberger, M.4    Yeshurun, M.5    Leibovici, L.6    Paul, M.7
  • 91
    • 58849147928 scopus 로고    scopus 로고
    • Newer antifungal agents for invasive fungal infections in patients with haematological malignancy
    • Rogers, T.R. & Frost, S. (2009) Newer antifungal agents for invasive fungal infections in patients with haematological malignancy. British Journal of Haematology, 144, 629-641.
    • (2009) British Journal of Haematology , vol.144 , pp. 629-641
    • Rogers, T.R.1    Frost, S.2
  • 92
    • 0033014809 scopus 로고    scopus 로고
    • Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group
    • Rotstein, C., Bow, E.J., Laverdiere, M., Ioannou, S., Carr, D. & Moghaddam, N. (1999) Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group. Clinical Infectious Diseases, 28, 331-340.
    • (1999) Clinical Infectious Diseases , vol.28 , pp. 331-340
    • Rotstein, C.1    Bow, E.J.2    Laverdiere, M.3    Ioannou, S.4    Carr, D.5    Moghaddam, N.6
  • 94
    • 36749026613 scopus 로고    scopus 로고
    • Posaconazole: an extended-spectrum triazole antifungal agent
    • Schiller, D.S. & Fung, H. (2007) Posaconazole: an extended-spectrum triazole antifungal agent. Clinical Therapeutics, 29, 1862-1886.
    • (2007) Clinical Therapeutics , vol.29 , pp. 1862-1886
    • Schiller, D.S.1    Fung, H.2
  • 96
    • 33846434112 scopus 로고    scopus 로고
    • Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts
    • Segal, B.H., Almyroudis, N.G., Battiwalla, M., Herbrecht, R., Perfect, J.R. & Walsh, T.J. (2007) Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. Clinical Infectious Diseases, 44, 402-409.
    • (2007) Clinical Infectious Diseases , vol.44 , pp. 402-409
    • Segal, B.H.1    Almyroudis, N.G.2    Battiwalla, M.3    Herbrecht, R.4    Perfect, J.R.5    Walsh, T.J.6
  • 99
    • 0028997086 scopus 로고
    • Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation-a prospective, randomized, double-blind study
    • Slavin, M.A., Osborne, B., Adams, R., Levenstein, M.J., Schoch, H.G., Feldman, A.R., Meyers, J.D. & Bowden, R.A. (1995) Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation-a prospective, randomized, double-blind study. Journal of Infectious Diseases, 171, 1545-1552.
    • (1995) Journal of Infectious Diseases , vol.171 , pp. 1545-1552
    • Slavin, M.A.1    Osborne, B.2    Adams, R.3    Levenstein, M.J.4    Schoch, H.G.5    Feldman, A.R.6    Meyers, J.D.7    Bowden, R.A.8
  • 101
    • 0012956488 scopus 로고
    • Amphotericin B, a new antifungal agent for the prophylaxis of antibiotic-induced moniliasis
    • Stough, A.R., Groel, J.T. & Kroeger, W.H. (1959) Amphotericin B, a new antifungal agent for the prophylaxis of antibiotic-induced moniliasis. Antibiotic Medicines and Clinical Therapy, 6, 653-661.
    • (1959) Antibiotic Medicines and Clinical Therapy , vol.6 , pp. 653-661
    • Stough, A.R.1    Groel, J.T.2    Kroeger, W.H.3
  • 102
    • 4043077767 scopus 로고    scopus 로고
    • Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation
    • Thursky, K.A., Byrnes, G., Grigg, A., Szer, J. & Slavin, M.A. (2004) Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation. Bone Marrow Transplantation, 34, 115-121.
    • (2004) Bone Marrow Transplantation , vol.34 , pp. 115-121
    • Thursky, K.A.1    Byrnes, G.2    Grigg, A.3    Szer, J.4    Slavin, M.A.5
  • 103
    • 33644790476 scopus 로고    scopus 로고
    • Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab
    • Thursky, K.A., Worth, L.J., Seymour, J.F., Prince, H.M. & Slavin, M.A. (2006) Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab. British Journal of Haematology, 132, 3-12.
    • (2006) British Journal of Haematology , vol.132 , pp. 3-12
    • Thursky, K.A.1    Worth, L.J.2    Seymour, J.F.3    Prince, H.M.4    Slavin, M.A.5
  • 104
    • 0027715740 scopus 로고
    • Randomized double-blind study of liposomal amphotericin B (AmBisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients
    • Tollemar, J., Ringden, O., Andersson, S., Sundberg, B., Ljungman, P. & Tydén, G. (1993) Randomized double-blind study of liposomal amphotericin B (AmBisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients. Bone Marrow Transplantation, 12, 577-582.
    • (1993) Bone Marrow Transplantation , vol.12 , pp. 577-582
    • Tollemar, J.1    Ringden, O.2    Andersson, S.3    Sundberg, B.4    Ljungman, P.5    Tydén, G.6
  • 106
    • 34547782213 scopus 로고    scopus 로고
    • Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient
    • Tong, S.Y., Peleg, A.Y., Yoong, J., Handke, R., Szer, J. & Slavin, M. (2007) Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient. Transplant Infectious Diseases, 9, 241-243.
    • (2007) Transplant Infectious Diseases , vol.9 , pp. 241-243
    • Tong, S.Y.1    Peleg, A.Y.2    Yoong, J.3    Handke, R.4    Szer, J.5    Slavin, M.6
  • 107
    • 0023209654 scopus 로고
    • Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies
    • Tricot, G., Joosten, E., Boogaerts, M.A., Vande Pitte, J. & Cauwenbergh, G. (1987) Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. Reviews in Infectious Diseases, 9(Suppl 1), S94-S99.
    • (1987) Reviews in Infectious Diseases , vol.9 , Issue.SUPPL. 1
    • Tricot, G.1    Joosten, E.2    Boogaerts, M.A.3    Vande Pitte, J.4    Cauwenbergh, G.5
  • 108
    • 15544367832 scopus 로고    scopus 로고
    • Antimicrobial prophylaxis in hematopoietic stem cell transplant recipients: heterogeneity of current clinical practice
    • Trifilio, S., Verma, A. & Mehta, J. (2004) Antimicrobial prophylaxis in hematopoietic stem cell transplant recipients: heterogeneity of current clinical practice. Bone Marrow Transplantation, 33, 735-739.
    • (2004) Bone Marrow Transplantation , vol.33 , pp. 735-739
    • Trifilio, S.1    Verma, A.2    Mehta, J.3
  • 110
    • 33846934215 scopus 로고    scopus 로고
    • Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality
    • Upton, A., Kirby, K.A., Carpenter, P., Boeckh, M. & Marr, K.A. (2007) Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clinical Infectious Diseases, 44, 531-540.
    • (2007) Clinical Infectious Diseases , vol.44 , pp. 531-540
    • Upton, A.1    Kirby, K.A.2    Carpenter, P.3    Boeckh, M.4    Marr, K.A.5
  • 112
    • 0015490690 scopus 로고
    • Miconazole, a broad-spectrum antimycotic agent with antibacterial activity
    • Van Cutsem, J.M. & Thienpont, D. (1972) Miconazole, a broad-spectrum antimycotic agent with antibacterial activity. Chemotherapy, 17, 392-404.
    • (1972) Chemotherapy , vol.17 , pp. 392-404
    • Van Cutsem, J.M.1    Thienpont, D.2
  • 113
    • 27744597532 scopus 로고    scopus 로고
    • Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials
    • Vardakas, K.Z., Michalopoulos, A. & Falagas, M.E. (2005) Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials. British Journal of Haematology, 131, 22-28.
    • (2005) British Journal of Haematology , vol.131 , pp. 22-28
    • Vardakas, K.Z.1    Michalopoulos, A.2    Falagas, M.E.3
  • 119
    • 0023625187 scopus 로고
    • Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole
    • Wingard, J.R., Vaughan, W.P., Braine, H.G., Merz, W.G. & Saral, R. (1987) Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole. American Journal of Medicine, 83, 1103-1110.
    • (1987) American Journal of Medicine , vol.83 , pp. 1103-1110
    • Wingard, J.R.1    Vaughan, W.P.2    Braine, H.G.3    Merz, W.G.4    Saral, R.5
  • 122
    • 0037736664 scopus 로고    scopus 로고
    • Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial
    • Winston, D.J., Maziarz, R.T., Chandrasekar, P.H., Lazarus, H.M., Goldman, M., Blumer, J.L., Leitz, G.J. & Territo, M.C. (2003) Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial. Annals of Internal Medicine, 138, 705-713.
    • (2003) Annals of Internal Medicine , vol.138 , pp. 705-713
    • Winston, D.J.1    Maziarz, R.T.2    Chandrasekar, P.H.3    Lazarus, H.M.4    Goldman, M.5    Blumer, J.L.6    Leitz, G.J.7    Territo, M.C.8
  • 123
    • 79957574721 scopus 로고    scopus 로고
    • Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem-cell transplantation recipients
    • Winston, D.J., Bartoni, K., Territo, M.C. & Schiller, G.J. (2010) Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem-cell transplantation recipients. Biology of Blood and Marrow Transplantation, doi:
    • (2010) Biology of Blood and Marrow Transplantation
    • Winston, D.J.1    Bartoni, K.2    Territo, M.C.3    Schiller, G.J.4
  • 124
    • 71449090672 scopus 로고    scopus 로고
    • Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients
    • Wirk, B. & Wingard, J.R. (2009) Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients. Mycopathologia, 168, 299-311.
    • (2009) Mycopathologia , vol.168 , pp. 299-311
    • Wirk, B.1    Wingard, J.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.